Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.
about
The ever-expanding role of HIF in tumour and stromal biologyPlastic roles of pericytes in the blood-retinal barrier.Dual role of pericyte α6β1-integrin in tumour blood vessels.Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.Interleukin-6 Stimulates Defective Angiogenesis.Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma.The challenge of targeting metastasis.Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival.Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2.Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapyThe Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.Sunitinib Treatment Enhances Metastasis of Innately Drug-Resistant Breast Tumors.Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasisImaging the Tumor Microenvironment.Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.Pericyte-expressed Tie2 controls angiogenesis and vessel maturation.Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Accelerated tumour metastasis due to interferon-γ receptor-mediated dissociation of perivascular cells from blood vessels.Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.Angiopoietin pathway gene expression associated with poor breast cancer survival.Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma.Therapeutic targeting of the angiopoietin-TIE pathway.Microenvironmental regulation of tumour angiogenesis.Platelet "first responders" in wound response, cancer, and metastasis.Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancerVascular Mimicry: The Next Big Glioblastoma Target.Therapeutic uses of epicatechin in diabetes and cancer.Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model.Demethylation of the MIR145 promoter suppresses migration and invasion in breast cancer.Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers.Inhibition of Lysyl Oxidases Impairs Migration and Angiogenic Properties of Tumor-Associated Pericytes.KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis.Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts.Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?PDGFRβ-P2A-CreERT2 mice: a genetic tool to target pericytes in angiogenesis.Gradual Suppression of Transcytosis Governs Functional Blood-Retinal Barrier Formation.Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses.The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors.The role of tumor microenvironment in resistance to anti-angiogenic therapy.
P2860
Q28079015-FE89667A-23D1-4E72-9349-EE286E1D3218Q33716453-CD27EB6B-7EF1-44C7-9C76-BAEB757A3FD5Q33743181-8C425656-715B-42AB-95CD-2BDBE30A8CCFQ34045380-FDAE4B7D-5975-479E-A9A9-C7A7BEDA8143Q35923153-631D41EE-1861-4309-BEB9-CA3C5B882D3CQ35995721-F23D7239-A4A4-4A14-90DE-C147E0D05585Q36322825-F9F7A755-E2D8-4478-8CD3-28F1173FD4C8Q36831553-3FFE3AB8-D30D-40F6-A5C6-453D71BA4BE0Q36831642-4F2388AB-BE4D-4862-8FD9-6F5AE235B532Q37138981-241C9A03-600B-4831-B223-B71322B59768Q37509823-FA820CF9-D969-40A2-9EA3-7B19ED1FD188Q37516448-25CE7324-D03C-4195-BC51-51E5FB3B8B3FQ37660355-00C1AC4D-F7DD-49BC-A6F4-279929EB0032Q37728585-B6DBA21D-E922-4B4D-AE39-03BC2EB2D1D5Q38518224-9B0B2E59-6C02-4597-9738-C5D635A0FFE4Q38592520-7D61D402-76F1-4067-832D-1023F29A972EQ38673791-639CB0BC-8184-4D3C-987F-BF45FC62DD8DQ38682486-823A6FDA-1CBD-4E81-BD4E-5D2534B89794Q38707139-F3E4BDC9-FC47-467D-B4CF-A1CA6F35A42AQ38941996-BF3E627C-0867-49FA-BCBD-9717E8C85812Q39034717-456FAAAC-ED04-407E-B9E1-1D4C702F5263Q39119400-9601246A-F509-4C83-8013-71DB6F3E72DBQ39321127-6B8BCE1A-B3C1-4A7B-9D59-B06FF3861F9DQ39433862-FFD04BE5-F0FB-44DA-88F3-3F710CD457D5Q39449769-017D8BE4-6307-49B3-B486-5E1F5CD4CA8FQ39542406-847A53DB-95E2-49FF-9A15-2E2A17539173Q39691814-C64AA066-60CD-4C2A-88FD-7E1B0F238773Q41469702-231DF70E-4113-4419-BF93-296BA85B4099Q41632271-C033E036-EC15-4761-AE4A-1BE8BD6C3E24Q41967527-BCF6175A-2924-48C6-822C-FE965F0D11CFQ42067472-3C050661-6466-416D-8C02-0864B60DF90EQ42261768-B9A81004-FB89-4C46-BAA4-ED92FFE6A266Q45067616-4E1FACF8-8CED-413C-9C29-31B514176915Q47162968-DEC3CAB5-86C1-439F-9026-3EAC6FB16408Q47893488-E4E1514A-1CAC-4E81-B512-F567154E9E2BQ48175878-BD614808-C327-4E82-9F3E-47A0269E2567Q48249430-195910AC-51AA-4DFF-BB1E-EBCE08C812B4Q49694802-2AD998DA-7AB4-454D-9D20-EB19CC93A4D7Q51822856-DEEE0B08-5803-4C5C-8F4A-A86F340E8B6EQ52645823-AE0468C5-54D8-4B75-B6CF-F3082815F5FB
P2860
Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Targeting vascular pericytes i ...... metastasis via angiopoietin-2.
@ast
Targeting vascular pericytes i ...... metastasis via angiopoietin-2.
@en
type
label
Targeting vascular pericytes i ...... metastasis via angiopoietin-2.
@ast
Targeting vascular pericytes i ...... metastasis via angiopoietin-2.
@en
prefLabel
Targeting vascular pericytes i ...... metastasis via angiopoietin-2.
@ast
Targeting vascular pericytes i ...... metastasis via angiopoietin-2.
@en
P2093
P2860
P1433
P1476
Targeting vascular pericytes i ...... metastasis via angiopoietin-2
@en
P2093
Chenghua Gu
Doruk Keskin
Hikaru Sugimoto
Michele De Palma
Raghu Kalluri
Valerie S LeBleu
Vesselina G Cooke
P2860
P304
P356
10.1016/J.CELREP.2015.01.035
P50
P577
2015-02-19T00:00:00Z